Biocon Limited

Biocon Limited is India's premier biotechnology company listed in National Stock Exchange since March 2004. Biocon was established in 1978, by Kiran Mazumdar Shaw in the garage of her rented house in Bangalore, with Rs.10,000. Headquartered in Bangalore, Biocon has evolved from an enzyme company to a fully integrated biopharmaceutical enterprise, focused on healthcare. In 2007, Biocon made a strategic decision to divest its historic enzymes business to Novozymes A/S of Denmark.

Biocon Limited and its two subsidiary companies, Syngene International Limited and Clinigene International Limited form a fully integrated biotechnology enterprise specializing in biopharmaceuticals, custom research and clinical research.The company applies its proprietary fermentation technologies to make effective and innovative biomolecules in diabetology, oncology, cardiology and other therapeutic segments.

Biocon Park comprises an integrated cluster of research laboratories and manufacturing facilities laid out on a 90 acre expanse in Bommasandra Industrial Area – Phase IV, near Electronic City. Biocon Park is focused on exports of both bio-pharmaceutical products and research services. The multi-product facilities mainly cater to the following disease segments: cardiovascular, cholesterol reduction, immunosuppressants in organ transplantation, diabetes and cancer.

Achievements

Some of the many achievements are:

• India's first biotechnology company to export microbial enzymes to USA and Europe
• First biotechnology company to receive ISO 9001 certification in India
• Syngene, is India's first custom research company in drug discovery
• Clinigene, has India's first CAP (College of American Pathologists) accredited clinical research laboratory
• Biotech Product and Process Development and Commercialisation Award, 2001 by the Department of Biotechnology, Ministry of Science and Technology, Government of India
• First company, globally to manufacture human insulin, INSUGEN®, using a Pichia expression system, 2004
• Biocon launched BIOMAb EGFR™, the first indigenously developed humanized monoclonal antibody for head & neck cancer

Biocon extends its support to numerous community outreach and corporate citizenship initiatives with special concentration in the areas of healthcare, education and environment. The Biocon Foundation, set up in 2004 has launched Arogya Raksha Yojana, a unique health initiative for rural India.

Biocon Limited Corporate Headquarters 20th KM, Hosur Road Bangalore - 560 100 http://www.biocon.com

Location